Психопатологическая структура апатической депрессии

165. Judd L. L., Akiskai H. S., Мaser J. D. et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders // Arch. Gen. Psychiatry. 1997. Vol. 55. P. 694–700.

166. Kaplan H., Sadock J. Клиническая психиатрия. М., 1998. C.278–360.

167. Katon W., Von Korff M., Lin E. et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial // Arch. Gen. Psychiatry. 1999. Vol. 56. P. 1109–1115.

168. Katzelnick D. J., Simon G. E., Pearson S. D. et al. Randomized trial of a depression management program in high utilizers of medical care // Arch. Fam. Med. 2000. Vol. 9. P. 345–351.

169. Kessler R. C., McGonagle K. A., Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey // Arch. Gen. Psychiatry. 1994. Vol. 51. P. 8–19.

170. Kessler R. C., Frank R. G. The impact of psychiatric disorders on work loss days // Psychol. Med. 1997. Vol. 27. Р. 861–873.

171. Kielholz P. Psychische krankhut n. Stress // Schweis. Arch. Neurol. Psychiatr. 1977. Bd.121. № 1. P.9–19.

172. Kielholz P. Chronisce endogene Depressionen // Chronische endogene Psychosen / Hrsg. H. von Kranz, K. Heinrich. Stutgart, 1973. S.5–7.

173. Kielholz P. Die Depression in der taglichen Praxis. Bern, 1974.

174. Kind P., Sorensen J. Modeling the cost-effectiveness of the prophylactic use of SSRIs in the treatment of depression // Int. Clin. Psychopharmacol. 1995. Vol. 10. Suppl. 1. P. 41–48.

175. Kind P., Sorensen J. The costs of depression // Int. Clin. Psychopharmacol. 1993. Vol. 7. P. 191–195.

176. Kowacs M., Deinberg T. L., Crouse-Novar M. A. et al. Depressive disorders in childhood // Arch. Gen. Psychiat. 1984. Vol.41. P.223–237.

177. Kraepelin E. Psychiatrie. 8 Aufl Bd. 1–4. Leipzig: Barth, 1909–1915.

178. Kupfer D. J., Frank E. Maintenance therapy for chronic depression // Arch. Gen. Psychiatry. 1996. Vol. 53. P. 775–776.

179. Lader M. H., Wing L. Physiological measures in agitated and retarded depressed patients // J. Psychiatr. Res. 1969. Vol.7 (2). P.89–100.

180. Leonhard K. Aufteilung der Endogenen Psychosen. Berlin, 1957.

181. Lepine L. P., Gastpar M., Mendlewicz J. et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society) // Int. Clin. Psychopharmacol. 1997. Vol. 12. P. 19–29.

182. Lesperance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review // J. Psychosom. Res. 2000. Vol. 48. Р. 379–391.

183. Levy M. L., Cummings J. L., Fairbanks L. A. et al. Apathy is not depression // J. Neuropsychiatry Clin. Neurosci. 1998. Vol.10 (3). P.314–319.

184. MacDonald T. M., Reid I. C., McMahon A. D. Patients receive an inadequate dose of antidepressants for an inadequate period // Br. Med. J. 1997. Vol. 315. P. 56–58.

185. Marin R. S. Differential diagnosis and classification of apathy // Am. J. Psychiatry. 1990. Vol.147 (1). P.22–30.

186. Marin R. S, Butters M. A., Mulsant B. H. et al. Apathy and executive function in depressed elderly // J. Geriatr. Psychiatry Neurol. 2003. Vol.16 (2). P.112–116.

187. Marin R. S., Firinciogullari S., Biedrzycki R. C. The sources of convergence between measures of apathy and depression // J. Affect. Disord. 1993. Vol.28 (1). P.7–14.

188. McManus P., Mant A., Mitchell P. et al. Use of antidepressants by general practitioners and psychiatrists in Australia // Austral. N. Z. J. Psychiatry. 2003. Vol. 37. P. 184–189.

189. Menier J., Lfo P. Privative syndrome of brain-injured patients (aboulia, asthenia, apathy, ataraxia) // Ann. Med. Psychol. (Paris).1980. Vol. 138. P.261–275.

190. Montgomery S. A., Kasper S. Comparison of compliance between selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis // Int. Clin. Psychopharmacol. 1995. Vol. 9. Suppl. 4. P. 33–40.

191. Mueller T. I., Leon A. C., Keller M. B. et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up // Am. J. Psychiatry. 1999. Vol. 156. P. 1000–1006.

192. Murray J. L., Lopez A. D. (Eds). The global burden of disease: a comprehensive assessment of morality and disability from disease. Injuries and risk factors in 1990 and projected to 2020 (Summury). WHO, World Bank, Harvard School of Public Health, 1996.

193. Nelson J., Charney D. The symptoms of Major Depressive illness // Am. J. Psychiatr. 1981. Vol.138. № 1. P.1–13.

194. Nuijten M., Hardens M., Souetre E. A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression // Pharmacoеconomics. 1995. Vol. 8. P. 159–168.

195. Okasha A., Kamel M., Khalil A. et al. Academic difficulty among male Egyptian university students. I. Association with psychiatric morbidity // Br. J. Psychiatry. 1985. Vol.146. P.140–144.